Industry Symposia Program

How to watch industry symposia from WCN’22

Did you miss any industry symposia sessions on February 25 and 26, 2022? Catch-up now! All industry symposia are available to watch on-demand until May 31, 2022. Sessions are open-access so you can even follow without a full registration to WCN.

I am already registered to WCN: Enter the virtual congress and click Industry Symposia.

I do not have a WCN registration: Register here for free with an open-access category registration. Enter the virtual congress and click Industry Symposia.

Industry programs

  • Vascular Calcification in CKD – The Hidden Threat
  • Organized by Sanofi
  • IN PERSON
    ON DEMAND
  • 09:00-10:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • HIF-PH Inhibitors – a Novel Option for Anemia Management-Expectations and Potential Concerns
  • Organized by Zydus Cadila
  • IN-PERSON
    VIRTUAL
    ON DEMAND
  • 12:00 – 13:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50
    11:50 – 12:00 Q&A All Faculty

  • Rise of Baxter’s Advanced Therapies
  • Organized by Baxter Malaysia
  • IN-PERSON
  • 12:00 – 13:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • A focus on IgAN – evolving challenges and therapeutic advances
  • Organized by Novartis
  • VIRTUAL
    ON DEMAND
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50
    11:50 – 12:00 Q&A All Faculty

  • Water quality for hemodialysis: An urgent need in developing economies to ensure patient safety
  • Organized by Fresenius Medical Care
  • VIRTUAL
    ON DEMAND
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • The evidence-based CKD clinic: Changing practice with SGLT2 inhibition
  • Sponsored by an unrestricted educational grant from AstraZeneca
  • VIEW PROGRAM HERE
  • VIRTUAL
    ON DEMAND
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Shortening the Path to an aTTP Diagnosis in the Nephrology Clinical Setting
  • Provided by Excel Continuing Education and
  • Supported by an educational grant from Sanofi Genzyme
  • VIRTUAL
    ON DEMAND
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Patient Report Outcome Measures (PROMs) in practice: how and why you should consider adding PROMs to your routine Chronic Kidney Disease (CKD) care
  • Organized by GSK
  • VIRTUAL
    ON DEMAND
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Looking upstream in IgAN: The role of the gut and its implications
  • Organized by Calliditas Therapeutics
  • VIRTUAL
    ON DEMAND
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • New Frontiers in the Treatment of Glomerular Diseases
  • Organized by Chinook Therapeutics
  • VIRTUAL
    ON DEMAND
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Dialysis treatment trends from a global perspective
  • Organized by Kyowa Kirin
  • IN-PERSON
    VIRTUAL
  • 09:00-10:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Bending the curve of CKD Medicine with SGLT2i in Malaysia
  • Organized by AstraZeneca
  • IN-PERSON
    VIRTUAL
  • 12:00 – 13:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • What has COVID taught us & How does the future look like
  • Organized by Baxter Malaysia
  • IN-PERSON
  • 12:00 – 13:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Application of Genetics in the Care of Kidney Patients
  • Organized by Sanofi
  • ON DEMAND
    VIRTUAL
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Super High Flux Dialyzer and Mortality in Hemodialysis Patient
  • Organized by Nipro Asia
  • ON DEMAND
    VIRTUAL
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Non-steroidal MRAs: Expanding the evidence-base in CKD and T2D and exploring new opportunities
  • Organized by Bayer
  • ON DEMAND
    VIRTUAL
  • 16:30 – 17:30 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • The Link Between Endothelin-1, Angiotensin II, and Proteinuria in the Pathophysiology of CKD
  • Organized by Travere Therapeutics
  • ON DEMAND
    VIRTUAL
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • The International Patient and Provider Voice in IgA Nephropathy
  • Organized by Otsuka
  • ON DEMAND
    VIRTUAL
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Addressing the unmet needs in complement-mediated kidney diseases
  • Organized by Novartis
  • ON DEMAND
    VIRTUAL
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Controversies in hyperkalaemia management and practical approaches
  • Sponsored by an unrestricted educational grant from AstraZeneca
  • VIEW PROGRAM HERE
  • ON DEMAND
    VIRTUAL
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • A Discussion with KDIGO: Advancing Evidence-Based Care in Diabetes and CKD
  • Sponsored by Boehringer Ingelheim & Lilly Alliance
  • ON DEMAND
    VIRTUAL
  • 23:00 – 00:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty

  • Relationship Between Blood Pressure Control and Treatment Adherence Among Your Hypertensive Patients
  • Organized by Abbott
  • IN-PERSON
  • 09:00 – 10:00 MYT
  • Time Title Speaker
    11:00 – 11:02 Welcome and Introduction
    11:02 – 11:10
    11:10 – 11:35
    11:35 – 11:50 s
    11:50 – 12:00 Q&A All Faculty